Literature DB >> 3013131

A comparison of the biological properties of type 2 plaque-producing agent derived from the Cal-1 strain of Marek's disease virus with other related viruses.

R Kirisawa, K Hirai, S Yachida, Y Kawakami, S Kato, T Mikami.   

Abstract

The serological and biological properties of the type 2 plaque-producing agent (PPA) derived from the Cal-1 strain of Marek's disease virus (MDV) were compared with those of reference strains of the three serotypes of MDV and herpesvirus of turkeys (HVT) groups; namely JM, HPRS-24 strains of MDV and the FC-126 strain of HVT for serotype 1, 2, and 3, respectively. By agar gel precipitation (AGP), indirect fluorescent antibody and virus neutralization tests, type 2 PPA was related but not identical to the FC-126 strain. By the AGP test, type 2 PPA showed a poor ability to synthesize B antigen and the A antigen was different from that of strain FC-126. To compare the virological characteristics of type 2 PPA with the reference strains, the release of cell-free virus into supernatants of infected cell cultures and titers of cell-free virus extracted sonically from infected cell cultures were examined. Cell-free type 2 PPA virus was easily detected in the supernatants and extracted from infected cell cultures. These properties were similar to reference strains of serotype 2 and 3. Next, the structural similarities of viral DNAs of type 2 PPA and strain FC-126 were examined by Southern blot hybridization. The restriction endonuclease-cleavage patterns of DNA of type 2 PPA were very similar but not identical to those of the FC-126 strain. In chickens inoculated with type 2 PPA, splenic lymphocytes supported a non-productive latent infection as did also those from chickens inoculated with the FC-126 or HPRS-24 strains. From these results, type 2 PPA appears to belong to serotype 3 of MDV and HVT groups. The origin of type 2 PPA is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013131     DOI: 10.1007/bf01309877

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  30 in total

1.  Comparative studies on Marek's disease virus and herpesvirus of turkey DNAs.

Authors:  K Hirai; K Ikuta; S Kato
Journal:  J Gen Virol       Date:  1979-10       Impact factor: 3.891

2.  Lyophilization of cell-free Marek's disease herpesvirus and a herpesvirus from turkeys.

Authors:  B W Calnek; S B Hitchner; H K Adldinger
Journal:  Appl Microbiol       Date:  1970-11

3.  Plaque types and cell-free virus from tissue cultures infected with Cal-1 strain of herpesvirus associated with Marek's disease.

Authors:  T Mikami; R A Bankowski
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506

4.  Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus.

Authors:  R L Witter; K Nazerian; H G Purchase; G H Burgoyne
Journal:  Am J Vet Res       Date:  1970-03       Impact factor: 1.156

5.  An enzyme-linked immunosorbent assay for the detection of antibodies to Marek's disease virus.

Authors:  Y Q Cheng; L F Lee; E J Smith; R L Witter
Journal:  Avian Dis       Date:  1984 Oct-Dec       Impact factor: 1.577

6.  Comparative studies on antigens induced by turkey herpesvirus and Marek's disease virus. I. Agar gel precipitation and neutralization studies.

Authors:  S Yachida; T Mikami; M Onuma; H Izawa
Journal:  Zentralbl Veterinarmed B       Date:  1983-09

7.  Comparative studies on antigens induced by turkey herpesvirus and Marek's disease virus. II. Immunofluorescent studies.

Authors:  S Yachida; T Mikami; M Onuma; H Izawa
Journal:  Zentralbl Veterinarmed B       Date:  1983-10

8.  In vivo and in vitro infections of chicken lymphocytes with Marek's disease virus or herpesvirus of turkeys.

Authors:  R Kirisawa; T Mikami
Journal:  Nihon Juigaku Zasshi       Date:  1983-12

9.  Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.

Authors:  L F Lee; X Liu; R L Witter
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

10.  Restriction endonuclease analysis of the genomes of virulent and avirulent Marek's disease viruses.

Authors:  K Hirai; K Ikuta; S Kato
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.